Biofern Life Sciences Private Limited

Biofern Life Sciences Private Limited - pharma in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
CIN U24100KA2019PTC120330 Incorporated 11 January 2019 ROC Bangalore HQ Bengaluru, Karnataka, India
Active Private Limited Company pharma
Revenue · FY 2025
₹15.4 Cr
▲ 177% YoY
Net profit · FY 2025
₹2.63 Cr
Net margin 17.1%
EBITDA · FY 2025
₹2.88 Cr
EBITDA margin 18.7%
Authorised capital
₹27 Cr
Registered with MCA
Paid-up capital
₹27 Cr
Issued & subscribed
Open charges
₹17.87 Cr
Satisfied ₹13 Cr
Company age
7 yrs
Est. 2019
Employees · EPFO
94
Provident fund records

About Biofern Life Sciences Private Limited

Data last updated:

Biofern Life Sciences Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 January 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24100KA2019PTC120330. Its GSTIN is 29AAICB2173J1ZG (Karnataka).

The company has an authorised share capital of ₹27 Cr and a paid-up capital of ₹27 Cr. It is led by directors including Kolathur Srinarayanan and Burugupalli Srinivas.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 706 Ground Floor 3 A Cross 1st Block Hrbr Layout Kalyan Nagar, Bengaluru, Karnataka, India – 560043.

As per the financials filed for FY 2025, the company reported a revenue of ₹15.4 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.63 Cr (net margin 17.1%) and EBITDA of ₹2.88 Cr (EBITDA margin 18.7%).

The company has about 94 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Biofern Life Sciences. As per MCA filings, the company has open charges of ₹17.87 Cr and satisfied charges of ₹13 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending. The company has 2 deals on record (2 rights issues); the latest was in December 2021. Its 10 peer companies in the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 5 smaller; the largest is Umarai Worldwide Private Limited with revenue of ₹15.4 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biofern.in.

Company details

CIN U24100KA2019PTC120330
Registration Number 120330
Incorporation Date 11 January 2019
ROC Bangalore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Biofern Life Sciences Private Limited's registered office is in Bengaluru, Karnataka. Its website is biofern.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    No. 706 Ground Floor 3 A Cross 1st Block Hrbr Layout Kalyan Nagar, Bengaluru, Karnataka, India – 560043
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Biofern Life Sciences Private Limited, buy the company report.

Comprehensive company report
Biofern Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Biofern Life Sciences operates one associated brand: Biofern Life Sciences. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures custom vitamins, minerals, health supplements, and specialty tablets for partners.biofern.in

Business activity

The main business activity of Biofern Life Sciences is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Biofern Life Sciences Private Limited, buy the company report.

Financials of Biofern Life Sciences Private Limited

FY 2025 filings available

Biofern Life Sciences Private Limited reported revenue of ₹15.4 Cr (up 177% YoY) for FY 2025.

Revenue · FY 2025
₹15.4 Cr ▲ 177%
Net profit · FY 2025
₹2.63 Cr margin 17.1%
EBITDA · FY 2025
₹2.88 Cr margin 18.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 177%
EBITDA CAGR growth
1 year
▲ 66%
3 years · compounded
▲ 174%

Revenue rose 177% in the latest year. EBITDA rose 66% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.88 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.63 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin18.7%
Net Profit Margin17.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Biofern Life Sciences Private Limited, buy the company report.

Board of directors of Biofern Life Sciences Private Limited

Biofern Life Sciences has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kolathur SrinarayananDirector11 Jan 20197 Years 10 MonthsCurrent
Burugupalli SrinivasDirector11 Jan 20197 Years 10 MonthsCurrent
Garikipati Kishore KumarDirector11 Jan 20197 Years 10 MonthsCurrent

Peer comparison

Biofern Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Umarai Worldwide Private Limited₹15.4 Cr (FY 2016)0.0%Navi Mumbai, Maharashtra, India
Absford Healthcare Private Limited₹15.4 Cr (FY 2024)19.0%Patna, Bihar, India
Tekminders IT Services International Private Limited₹15.4 Cr (FY 2025)-12.0%Bangalore, Karnataka, India
R B Kissan Kendra Private Limited₹15.4 Cr (FY 2025)-66.0%Delhi, India
Curano Healthcare Private Limited₹15.4 Cr (FY 2025)72.0%Bikaner, Rajasthan, India
Biofern Life Sciences Private Limitedthis company₹15.4 Cr (FY 2025)₹2.63 Cr17.1%177.0%94Bengaluru, Karnataka, India
Espiem Engines and Machines Private Limited₹15.4 Cr (FY 2025)74.0%Kanpur, Uttar Pradesh, India
Shankh Feeds Private Limited₹15.4 Cr (FY 2024)12314.0%Gopalganj, Bihar, India
Debendranath Mitra Lab Private Limited₹15.39 Cr (FY 2024)36.0%Ranaghat, West Bengal, India
Marvel Ispat Private Limited₹15.39 Cr (FY 2025)-3.0%Surat, Gujarat, India
LDC Metal & Minerals Private Limited₹15.39 Cr (FY 2025)-19.0%Kolkata, West Bengal, India

To see the full peer comparison of Biofern Life Sciences Private Limited, buy the company report.

Auditor

Biofern Life Sciences Private Limited is audited by Navin Nayak & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Navin Nayak & AssociatesFY 2023014367S

Shareholding

The shareholding of Biofern Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Biofern Life Sciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹17.87 Cr
Satisfied charges
₹13 Cr
Breakdown by lending institutions
Axis Bank Limited₹17.87 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Nov 2023100828149Axis Bank Limited₹17.87 CrOpen
24 Jul 2023100764930Karnataka Bank Ltd.₹2 CrSatisfied
18 Apr 2023100716099Karnataka Bank Ltd.₹3 CrSatisfied
16 Jun 2022100589838Karnataka Bank Ltd.₹8 CrSatisfied

To see the full charge records of Biofern Life Sciences Private Limited, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Biofern Life Sciences Private Limited has 2 deals on record (2 rights issues); the latest was in December 2021.

Total deals
2
Rights issues
2

Deals on record (2 of 2)

WhenDealAmountParties
Dec 2021Rights issue₹13.91 CrInvestors: 4 individuals
Apr 2021Rights issue₹8.16 CrInvestors: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Biofern Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Biofern Life Sciences Private Limited has a workforce of 94 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
94
Active EPFO establishments
1
Employee growth
14.6%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2794
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23

To see the full employee and EPFO history of Biofern Life Sciences Private Limited, buy the company report.

GST

Biofern Life Sciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAICB2173J1ZGKarnatakaActive13 Jul 2021

To see the full GST registrations and return filing status of Biofern Life Sciences Private Limited, buy the company report.

Recent activity

Biofern Life Sciences Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Burugupalli Srinivas was appointed as Director on 11 Jan 2019.

Charges
A charge with Axis Bank Limited of Rs. 17.87 Cr registered on 17 Nov 2023 with Charge ID 100828149 was modified on 07 Jan 2026.
AGM
Biofern Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biofern Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge registered on 24 Jul 2023 via Charge ID 100764930 with Karnataka Bank Ltd. was fully satisfied on 19 Apr 2024.
Charges
A charge registered on 18 Apr 2023 via Charge ID 100716099 with Karnataka Bank Ltd. was fully satisfied on 19 Apr 2024.
Charges
A charge registered on 16 Jun 2022 via Charge ID 100589838 with Karnataka Bank Ltd. was fully satisfied on 18 Apr 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 17.87 Cr with Charge ID 100828149 was registered on 17 Nov 2023.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 2.00 Cr with Charge ID 100764930 was registered on 24 Jul 2023.
Charges
A charge with Karnataka Bank Ltd. of Rs. 3.00 Cr registered on 18 Apr 2023 with Charge ID 100716099 was modified on 24 Jul 2023.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 3.00 Cr with Charge ID 100716099 was registered on 18 Apr 2023.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 8.00 Cr with Charge ID 100589838 was registered on 16 Jun 2022.
Appointed
Burugupalli Srinivas was appointed as Director.

3 earlier events are in the company report.

Frequently asked questions

Biofern Life Sciences is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 January 2019 (7+ years old) and is registered under CIN U24100KA2019PTC120330.

Biofern Life Sciences has 3 current directors:

The latest financial statements of Biofern Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Biofern Life Sciences is 29AAICB2173J1ZG, registered in Karnataka.

The CIN (Corporate Identification Number) of Biofern Life Sciences is U24100KA2019PTC120330. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Biofern Life Sciences has 2 court cases on record: 2 filed by the company. 2 are pending.

Biofern Life Sciences was incorporated on 11 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.

Biofern Life Sciences has 2 deals on record (2 rights issues); the latest was in December 2021.

The peers of Biofern Life Sciences by revenue are Umarai Worldwide Private Limited, Absford Healthcare Private Limited, Tekminders IT Services International Private Limited, R B Kissan Kendra Private Limited, Curano Healthcare Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Burugupalli Srinivas was appointed as Director on 11 Jan 2019. Garikipati Kishore Kumar was appointed as Director on 11 Jan 2019. Kolathur Srinarayanan was appointed as Director on 11 Jan 2019.

Biofern Life Sciences can be reached through the website biofern.in. Its registered office is in Bengaluru, Karnataka, India.